Answers are grounded in this paper and cite their sources.
Demonstrates improved pain relief in chronic pain patients, suggesting innovative stimulation methods are effective.
INTRODUCTION: Neuromodulation treatments are a well-established therapy for chronic pain patients. BurstDR is a novel spinal cord stimulation platform rooted in clinical and scientific data. BODY: It not only activates the lateral and descending pathways which are observed with traditional tonic stimulation but is able to activate the medial pathways and therefore effect the emotional and cognitive components of pain. It has been shown to be different than other "burst" platforms on the market which are intermittent tonic stimulation. It is a highly energy-efficient stimulation paradigm that operates on a "less is more" paradigm. EVIDENCE: has 6-month prospective data, 4-year real-world data, and trial data in addition to established scientific evidence with human electrophysiological recordings. CONCLUSION: The distinct characteristics of the BurstDR and multi-area Burst DR platforms not only deliver consistent pain relief but also lend itself to improving painfulness, suffering, disability, quality of life, pain intensity, and pain interference. The high levels of patient global impression of change demonstrate the considerable impact on the patients' lives.
No takes yet. Share an insight, caveat, or question.
Falowski et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: